Xenon Pharmaceuticals (XENE): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
Xenon Pharmaceuticals (XENE) neyrobiologiya sohasidagi yetakchi innovator sifatida baholanadi. PEG koeffitsiyenti biznesning o'sish sur'atlari bo'yicha bozor konsensusini vizuallashtiradi, bunda 0.00 joriy parametr qiymati vazifasini bajaradi. Moliyaviy barqarorlik epilepsiya tadqiqotlarining no-tsiklik tabiatiga tayanadi, garchi mahsulotlar tijoratlashtirilgunga qadar pul oqimlari beqarorligicha qolayotgan bo'lsa-da. Investorlar klinik sinovlar bosqichi bilan bog'liq xatarlarni hisobga olishlari kerak.
Xenon Pharmaceuticals (XENE) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati xenon-pharma.com|XENE - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Xenon Pharmaceuticals Inc|XENE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Xenon Pharmaceuticals|Oraliq qoplash koeffitsiyenti xenon-pharma.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
XENE - Kompaniyaning sof foydasi|Kelajakdagi foyda Xenon Pharmaceuticals|XENE - P/E multiplikatori|Forvard P/E multiplikatori Xenon Corp|XENE - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Xenon Pharmaceuticals Inc|XENE - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Xenon Pharmaceuticals|XENE - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi xenon-pharma.com|XENE - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Xenon Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:Xenon Pharmaceuticals Inc., XENE
PEG koeffitsiyenti foydaning bozor qiymatini uning o'sish sur'ati bilan solishtiradi va qiymat birdan past bo'lganda, qadrsizlangan aktivlarni aniqlash imkonini beradi. Ushbu PEG grafikni tahlil qilish orqali investor Xenon Pharmaceuticals (XENE) kompaniyasining klinik sinovlar etikasi va laboratoriya energiya samaradorligi qanchalik darajada barqaror biznes kengayishiga olib kelishini baholashi hamda aksiyaning "raketa" kabi tez o'sish salohiyatiga ega yoki sekinlashish signalini berayotganini aniqlashi mumkin.
Raqobatdosh kompaniyalar
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|RGC: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|Viking Therapeutics, Inc. (VKTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti SUPN|Narx-foyda va o‘sish multiplikatori CPRX|DNLI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Harmony Biosciences (HRMY)|BHVN: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AMLX (Amylyx Pharmaceuticals, Inc.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVI|Praxis Medicines - PEG multiplikatori|AVXL - PEG multiplikatori|CeriBell, Inc. (CBLL) - Narxning foydaga va o‘sish sur’atiga nisbati|Prothena - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Alector Inc.|Narx-foyda va o‘sish multiplikatori Annexon Biosciences (ANNX)|PEG multiplikatori OMER|PEG multiplikatori Neurogene Therapeutics (NGNE)|PEG multiplikatori ACIU (AC Immune)|VYGR - Narx-foyda va o‘sish multiplikatori|Neumora Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scilex Holding|TVGN (Tevogen Bio Holdings, Inc.) - Narx-foyda va o‘sish multiplikatori|Alpha Cognition Inc. (ACOG) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CGTX|IKT (inhibikase.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori SAVA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati assertiotx.com|PEG multiplikatori COYA (Coya Therapeutics)|VTGN - Narx-foyda va o‘sish multiplikatori|Ovid Rx - PEG multiplikatori|ABOS - PEG multiplikatori|CervoMed (CRVO) - Narxning foydaga va o‘sish sur’atiga nisbati|ATHE (Alterity Therapeutics Limited) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|PepGen Corp (PEPG) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|relmada.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ANVS (Annovis Bio)|Grace Therapeutics Inc (GRCE) - O‘sish sur’atiga tuzatilgan narx-foyda|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NRSN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NRXS (NeurAxis Inc.)|PEG multiplikatori HSDT|PASG - O‘sish sur’atiga tuzatilgan narx-foyda|Neuphoria Therapeutics - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori minervaneurosciences.com NERV|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADXN (Addex Therapeutics Ltd.)|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Cyclerion Therapeutics, Inc. (CYCN)|Narx-foyda va o‘sish multiplikatori PTIX|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KTTA (Pasithea)|PEG multiplikatori CRGT|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|Narx-foyda va o‘sish multiplikatori MRNS|NKGN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori SNPX (Synaptogenix)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVN|Vigil Neuro - PEG multiplikatori|WENA - PEG multiplikatori|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
